Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : VRPX save search
Virpax Pharmaceuticals Reports 2023 Year-End Results
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: -0.68%
H: 3.17%
C: 2.65%
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: 11.11%
H: 0.0%
C: -10.0%
virpax pharmaceuticals results
Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
Published: 2024-02-27 (Crawled : 14:00) - biospace.com/
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: -14.39%
H: 7.35%
C: -0.24%
virpax pharmaceuticals
Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: -14.39%
H: 7.35%
C: -0.24%
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: 7.14%
H: 66.67%
C: -11.0%
virpax pharmaceuticals
Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research
Published: 2024-02-07 (Crawled : 13:30) - biospace.com/
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: -2.99%
H: 3.63%
C: -5.27%
institute virpax pharmaceuticals research pilot results study
Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
Published: 2023-11-17 (Crawled : 17:00) - biospace.com/
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 6.92%
H: 0.0%
C: -7.88%
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: 0.0%
H: 14.29%
C: 3.05%
nasdaq virpax pharmaceuticals
Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
Published: 2023-11-15 (Crawled : 00:00) - biospace.com/
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 0.0%
H: 0.0%
C: -7.25%
virpax pharmaceuticals results
Virpax Pharmaceuticals Announces that Envelta™ Remains on Track for Trial in Humans Following FDA Review
Published: 2023-10-31 (Crawled : 13:00) - virpaxpharma.com
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 0.0%
H: 4.75%
C: 3.47%
fda virpax review pharmaceuticals trial
Unveiling Innovative Strategies for Drug Development
Published: 2023-10-19 (Crawled : 01:00) - virpaxpharma.com
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 0.12%
H: 2.3%
C: 2.3%
drug
Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research
Published: 2023-10-12 (Crawled : 13:00) - biospace.com/
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 0.0%
H: 5.13%
C: 5.1%
institute virpax pharmaceuticals research extension
Gerald W. Bruce Appointed President and CEO of Novvae™ Pharmaceuticals
Published: 2023-10-02 (Crawled : 13:00) - virpaxpharma.com
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: -3.61%
H: 10.96%
C: 5.23%
ceo pharmaceuticals
Virpax Pharmaceuticals Announces Results of Probudur™ Dose Escalation Studies
Published: 2023-09-27 (Crawled : 13:00) - virpaxpharma.com
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 5.25%
H: 3.76%
C: -3.74%
virpax pharmaceuticals results
Virpax Pharmaceuticals to Present at the LD Micro Main Event XVI
Published: 2023-09-26 (Crawled : 13:00) - virpaxpharma.com
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: -6.36%
H: 10.94%
C: 5.41%
virpax pharmaceuticals
Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses
Published: 2023-09-22 (Crawled : 03:00) - virpaxpharma.com
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 5.77%
H: 0.0%
C: -4.94%
drug virpax
Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals
Published: 2023-09-18 (Crawled : 12:00) - virpaxpharma.com
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 0.13%
H: 0.0%
C: -2.59%
virpax pharmaceuticals
Virpax Pharmaceuticals Updates on Litigation
Published: 2023-09-05 (Crawled : 13:30) - virpaxpharma.com
SCLX | $0.9 -23.08% -30.84% 2.5M
|
|
| O: 0.0%
H: 4.52%
C: 2.9%
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 0.0%
H: 0.0%
C: -4.44%
virpax pharmaceuticals
Virpax® Pharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-08-28 (Crawled : 13:00) - virpaxpharma.com
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 2.62%
H: 0.1%
C: -1.66%
virpax conference pharmaceuticals global
Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments
Published: 2023-08-14 (Crawled : 17:00) - biospace.com/
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: -6.82%
H: 9.76%
C: 9.76%
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: -1.61%
H: 0.91%
C: -5.3%
virpax pharmaceuticals results
Transmucosal Drug Delivery Pipeline Research Report 2023: Formulate Effective R&D Strategies with Key Insights
Published: 2023-07-29 (Crawled : 00:20) - prnewswire.com
HALB | $0.008 -10.11% 7.14% 220K
|
n/a
| Email alert
Add to watchlist
KPRX | $0.51 0.75% -3.03% 130K
|
Manufacturing
| Email alert
Add to watchlist
VRPX | $4.04 16.43% 10.34% 20K
|
| Email alert
Add to watchlist
ELDN | $1.99 26.75% 21.11% 300K
|
Manufacturing
| Email alert
Add to watchlist
SEEL | $0.338 1.81% -3.11% 270K
|
Health Technology
| Email alert
Add to watchlist
drug report pipeline research
Virpax Pharmaceuticals Files Provisional Patent Application for Intranasal Delivery
Published: 2023-07-13 (Crawled : 14:00) - biospace.com/
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 0.0%
H: 4.9%
C: -3.92%
patent virpax pharmaceuticals application
Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council
Published: 2023-06-21 (Crawled : 13:00) - biospace.com/
VRPX | $4.04 16.43% 10.34% 20K
|
|
| O: 1.01%
H: 10.0%
C: -1.0%
stroke virpax pharmaceuticals neurological
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
UMAC | $1.55 0.65% 12.9% 0
|
TAOP | $1.08 13.01% 11.51% 19K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.